London & Essex Kidney Clinic
Dr Ibrahim Fahal

MBBS, MD, FRCP (London), FRCP (Glasgow)
Consultant Nephrologist & Senior Lecturer

Request An Appointment
020 7993 5352

Request An Appointment

020 7993 5352

twitter  facebook  linkedin  googleplus  pinterest  droppedImage  droppedImage 1

  • slideshow00.jpg
  • slideshow01.jpg
  • slideshow02.jpg
  • slideshow03.jpg
  • slideshow04.jpg
  • slideshow05.jpg
  • slideshow06.jpg

Welcome to London & Essex Kidney Clinic

Dr Ibrahim Fahal is both a clinician and a teacher. He did his undergraduate training at Khartoum University Medical School, where he learned not only how to be a doctor but also a compassionate physician. Since his consultant appointment in 1997, he has been continuously involved in patient care and teaching. He serves as an instructor for medical students from Queen Mary University of London and the American University of the Caribbean. He has published numerous scientific articles, contributed chapters to medical textbooks, and given hundreds of lectures at both national and international meetings. He offers private consultations in London and Brentwood.


About Dr Fahal

Click Here to Learn More



Click Here to Learn More



Click Here to Learn More

Dr Fahal Practices in the Following Hospitals

London Independent Hospital
London E1 4NL
Appointments: 020 7780 2400


Spire Hartswood Hospital
Brentwood Essex CM13 3LE
Appointments 01277 266 766


Nuffield Health Brentwood Hospital
Brentwood Essex CM15 8EH
Appointments: 01277 695 695


Spire Roding Hospital
Ilford IG4 5PZ
Appointments: 020 8709 7878

Antihypertensive therapy for the prevention of nephropathy in diabetic hypertensive patients

There was no literature evaluating antihypertensive therapies in preventing nephropathy in type 1 hypertensive diabetics. However, in patients with type 2 diabetes and hypertension, multiple studies demonstrate the benefit of an ACEI or ARB in preventing or delaying the onset of nephropathy, while no study demonstrated the benefit of a CCB over an ACEI or ARB.

Due to the lack of literature, hypertension management in type 1 diabetics with normoalbuminuria should be guided by the treatment of comorbidities. To prevent diabetic nephropathy, an ACEI or ARB should be first-line monotherapy over a CCB for the management of hypertension in patients with type 2 diabetes mellitus, hypertension and normoalbuminuria.

Journal of Clinical Pharmacy and Therapeutics. DOI: 10.1111/jcpt.12361